Statins inhibit monocyte chemotactic protein 1 expression in endometriosis

37Citations
Citations of this article
36Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Statins are potent inhibitors of the endogenous mevalonate pathway. Besides inhibiting cholesterol biosynthesis, statins may also demonstrate anti-inflammatory properties. Inflammation is implicated in the attachment and invasion of endometrial cells to the peritoneal surface and growth of ectopic endometrium by inducing proliferation and angiogenesis. In this study, the effect of statins on monocyte chemotactic protein 1 (MCP-1) expression in endometriotic implants in nude mouse model and in cultured endometriotic cells was evaluated. In mouse model, simvastatin decreased MCP-1 expression in a dose-dependent manner in endometriotic implants (P

Author supplied keywords

Cite

CITATION STYLE

APA

Cakmak, H., Basar, M., Seval-Celik, Y., Osteen, K. G., Duleba, A. J., Taylor, H. S., … Arici, A. (2012). Statins inhibit monocyte chemotactic protein 1 expression in endometriosis. Reproductive Sciences, 19(6), 572–579. https://doi.org/10.1177/1933719111430998

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free